Veeva Systems Inc. (VEEV)
NYSE: VEEV · Real-Time Price · USD
273.72
-3.29 (-1.19%)
At close: Nov 18, 2025, 4:00 PM EST
273.00
-0.72 (-0.26%)
Pre-market: Nov 19, 2025, 5:23 AM EST
Veeva Systems Revenue
Veeva Systems had revenue of $789.08M in the quarter ending July 31, 2025, with 16.70% growth. This brings the company's revenue in the last twelve months to $2.97B, up 15.33% year-over-year. In the fiscal year ending January 31, 2025, Veeva Systems had annual revenue of $2.75B with 16.20% growth.
Revenue (ttm)
$2.97B
Revenue Growth
+15.33%
P/S Ratio
15.00
Revenue / Employee
$407,107
Employees
7,291
Market Cap
44.86B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jan 31, 2025 | 2.75B | 382.95M | 16.20% |
| Jan 31, 2024 | 2.36B | 208.61M | 9.68% |
| Jan 31, 2023 | 2.16B | 304.28M | 16.44% |
| Jan 31, 2022 | 1.85B | 385.71M | 26.33% |
| Jan 31, 2021 | 1.47B | 360.99M | 32.70% |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
VEEV News
- 15 days ago - Veeva Basics Adopted by More Than 100 Emerging Biotechs to Simplify and Standardize Operations - PRNewsWire
- 19 days ago - Veeva to Release Fiscal 2026 Third Quarter Results on November 20, 2025 - PRNewsWire
- 4 weeks ago - Veeva Systems Inc. (VEEV) Analyst/Investor Day Transcript - Seeking Alpha
- 4 weeks ago - OpenEvidence and Veeva Announce Open Vista Partnership - PRNewsWire
- 5 weeks ago - Veeva AI Agents to Be Released Across All Veeva Applications - PRNewsWire
- 5 weeks ago - Big Money Boost – Veeva Up 975% Since 2015 - FXEmpire
- 5 weeks ago - 4 Top AI-Powered Healthcare Stocks - Seeking Alpha
- 7 weeks ago - Industry Research Finds Two-Thirds of Clinical Data Managers and CRAs Believe Current Inefficiencies Put Data Quality at Future Risk - PRNewsWire